Dabistar, containing the active ingredient Dabigatran Etexilate, is an anticoagulant medication used to reduce the risk of stroke and blood clots in patients with certain types of heart rhythm disorders, such as atrial fibrillation. It works by inhibiting thrombin, an enzyme that plays a key role in blood clotting.
Dabistar functions by directly inhibiting thrombin, which prevents the conversion of fibrinogen to fibrin, a crucial step in the formation of blood clots. This action helps to maintain normal blood flow and reduces the risk of thromboembolic events.
Dabistar is primarily prescribed for:
Some common side effects of Dabistar may include:
Dabistar is not suitable for everyone. Patients who should avoid this medication include:
Dabistar is typically taken orally, with or without food. It is important to follow the prescribed dosage and schedule provided by your healthcare provider. Do not discontinue or adjust the dosage without consulting your doctor.
Before starting Dabistar, inform your healthcare provider about:
Dabistar is a valuable medication for managing the risk of stroke and blood clots in specific patient populations. Always consult with your healthcare provider for personalized medical advice and to ensure the safe use of this medication.